RECENT ADVANCES

RECENT ADVANCES

Advanced technology , newer drugs and skin substitutes are the major advances in burn care. The next steps will focus on cultured autologous skin incorporating the patient’s own kera - tinocytes and fibroblasts. An intelligent use of these modalities is essential to make an e ff ective case for cost–benefit ratios. RECENT ADVANCES

Advanced technology , newer drugs and skin substitutes are the major advances in burn care. The next steps will focus on cultured autologous skin incorporating the patient’s own kera - tinocytes and fibroblasts. An intelligent use of these modalities is essential to make an e ff ective case for cost–benefit ratios. RECENT ADVANCES

Advanced technology , newer drugs and skin substitutes are the major advances in burn care. The next steps will focus on cultured autologous skin incorporating the patient’s own kera - tinocytes and fibroblasts. An intelligent use of these modalities is essential to make an e ff ective case for cost–benefit ratios.